Gene · 2053
Papers2,484
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 2,484
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Statins, commonly coprescribed drugs, and concomitant risk factors: A protective, neutral, or harmful association with common cancer types development: A 10-year multicentric retrospective lebanese study. | Medicine (Baltimore) | 2023 | 37773843 | PubTator, text mining | PubMed |
| New Sight: Enzymes as Targets for Drug Development. | Curr Issues Mol Biol | 2023 | 37754266 | PubTator, text mining | PubMed |
| Arachidonic acid metabolism in health and disease. | MedComm (2020) | 2023 | 37746665 | PubTator, text mining | PubMed |
| Bioactive lipid-based therapeutic approach to COVID-19 and other similar infections. | Arch Med Sci | 2023 | 37732033 | PubTator, text mining | PubMed |
| Network analysis of inflammation and symptoms in recent onset schizophrenia and the influence of minocycline during a clinical trial. | Transl Psychiatry | 2023 | 37723153 | PubTator, text mining | PubMed |
| Precision Oncology Comes of Age: Designing Best-in-Class Small Molecules by Integrating Two Decades of Advances in Chemistry, Target Biology, and Data Science. | Cancer Discov | 2023 | 37712571 | PubTator, text mining | PubMed |
| Molecular characterization of MRSA collected during national surveillance between 2008 and 2019 in the Netherlands. | Commun Med (Lond) | 2023 | 37700016 | PubTator, text mining | PubMed |
| In Silico Modeling and Structural Analysis of Soluble Epoxide Hydrolase Inhibitors for Enhanced Therapeutic Design. | Molecules | 2023 | 37687207 | PubTator, text mining | PubMed |
| The Effects of Early-Life Stress on Liver Transcriptomics and the Protective Role of EPA in a Mouse Model of Early-Life-Stress-Induced Adolescent Depression. | Int J Mol Sci | 2023 | 37685937 | PubTator, text mining | PubMed |
| The association between angiotensin receptor blockers and lung, bladder, and colon cancer development: A 10-year multicentric retrospective Lebanese study. | Medicine (Baltimore) | 2023 | 37682163 | PubTator, text mining | PubMed |
| Autonomy support encourages use of more-affected arm post-stroke. | J Neuroeng Rehabil | 2023 | 37679781 | PubTator, text mining | PubMed |
| Bioactive oxylipins in type 2 diabetes mellitus patients with and without hypertriglyceridemia. | Front Endocrinol (Lausanne) | 2023 | 37664847 | PubTator, text mining | PubMed |
| Insights into the inhibitory activities of neolignans and diarylnonanoid derivatives from nutmeg (Myristica fragrans Houtt.) seeds on soluble epoxide hydrolase using in vitro and in silico approaches. | J Enzyme Inhib Med Chem | 2023 | 37638797 | PubTator, text mining | PubMed |
| Adamantyl-ureas with pyrazoles substituted by fluoroalkanes as soluble epoxide hydrolase inhibitors. | J Fluor Chem | 2023 | 37638129 | PubTator, text mining | PubMed |
| Renin-Angiotensin System Components and Arachidonic Acid Metabolites as Biomarkers of COVID-19. | Biomedicines | 2023 | 37626615 | PubTator, text mining | PubMed |
| Integration of plasma and CSF metabolomics with CSF proteomic reveals novel associations between lipid mediators and central nervous system vascular and energy metabolism. | Sci Rep | 2023 | 37612324 | PubTator, text mining | PubMed |
| Soluble epoxide hydrolase maintains steady-state lipid turnover linked with autocrine signaling in peritoneal macrophages. | iScience | 2023 | 37599831 | PubTator, text mining | PubMed |
| Building Block-Based Binding Predictions for DNA-Encoded Libraries. | J Chem Inf Model | 2023 | 37578123 | PubTator, text mining | PubMed |
| Effects of short-chain per- and polyfluoroalkyl substances (PFAS) on human cytochrome P450 (CYP450) enzymes and human hepatocytes: An in vitro study. | Curr Res Toxicol | 2023 | 37575337 | PubTator, text mining | PubMed |
| HDAC3 and HDAC8 PROTAC dual degrader reveals roles of histone acetylation in gene regulation. | Cell Chem Biol | 2023 | 37572669 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2053/papers?page=15